D-Dopa

Levodopa & Carbidopa

Levodopa & Carbidopa

Composition : D-dopa 110 : Levodopa USP 100 mg + Carbidopa USP 10 mg Tablet.

D-dopa 275 : Levodopa USP 250 mg + Carbidopa USP 25 mg Tablet.

Indications : D-dopa is indicated for the treatment of idiopathic Parkinson's disease, post-encephalitic parkinsonism and symptomatic parkinsonism which may follow injury to the nervous system by carbon monoxide intoxication or manganese intoxication.

Dosage and administration : Dosage is initiated with 50-100mg Levodopa and 10- 12.5mg Carbidopa 3-4 times daily. If necessary dosage may be increased by 50-100mg daily or on alternate days according to response upto Levodopa 800mg and Carbidopa 80-100mg daily in divided doses. Or, as directed by the registered physician.

Pregnancy and lactation : Pregnancy Category C.

Packing :

D-dopa 110 : 3x10's tablets in blister pack.

D-dopa 275 : 5x10's tablets in blister pack.

Prescribing Description

Related Products

© Copyright Drug International Ltd. 2024 Designed and Developed by ATI Limited.